| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Canagliflozin | FAERS: 203 Canada Vigilance: 1 | Canada Vigilance SIDER US FAERS | |
| 2 | 2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol | FAERS: 28 | SIDER US FAERS | |
| 3 | Norgestrel | FAERS: 18 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | empagliflozin | FAERS: 14 | SIDER US FAERS | |
| 5 | 5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol | FAERS: 5 | US FAERS | |
| 6 | Glyxambi | FAERS: 5 | US FAERS | |
| 7 | Invokamet | FAERS: 5 | US FAERS | |
| 8 | Varenicline | FAERS: 5 | US FAERS | |
| 9 | Breo Ellipta | FAERS: 4 | US FAERS | |
| 10 | Pregabalin | FAERS: 4 | US FAERS | |
| 11 | Sunitinib | FAERS: 3 | US FAERS | |
| 12 | Dapagliflozin and metformin hydrochloride | FAERS: 2 | US FAERS | |
| 13 | Dimethyl Fumarate | FAERS: 2 | US FAERS | |
| 14 | Doxycycline | FAERS: 2 | US FAERS | |
| 15 | Isotretinoin | FAERS: 2 | US FAERS | |
| 16 | fesoterodine | FAERS: 2 | US FAERS | |
| 17 | linaclotide | FAERS: 2 | US FAERS | |
| 18 | liposomal doxorubicin | FAERS: 2 | US FAERS | |
| 19 | tofacitinib | FAERS: 2 | US FAERS | |
| 20 | AN2728 | FAERS: 1 | US FAERS | |
| 21 | Axitinib | FAERS: 1 | US FAERS | |
| 22 | Dabigatran | FAERS: 1 | US FAERS | |
| 23 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 24 | Everolimus | FAERS: 1 | US FAERS | |
| 25 | Guaifenesin | FAERS: 1 | US FAERS | |
| 26 | Memantine | FAERS: 1 | US FAERS | |
| 27 | Qsymia | FAERS: 1 | US FAERS | |
| 28 | Restasis | FAERS: 1 | US FAERS | |
| 29 | Rifaximin | FAERS: 1 | US FAERS | |
| 30 | Ruxolitinib phosphate | FAERS: 1 | US FAERS | |
| 31 | Sildenafil Citrate | FAERS: 1 | US FAERS | |
| 32 | Testosterone | FAERS: 1 | US FAERS | |
| 33 | Tiotropium Bromide | FAERS: 1 | US FAERS | |
| 34 | Trimethoprim, Sulfamethoxazole Drug Combination | FAERS: 1 | US FAERS | |
| 35 | Vardenafil Dihydrochloride | FAERS: 1 | US FAERS | |
| 36 | Vigabatrin | FAERS: 1 | US FAERS | |
| 37 | apixaban | FAERS: 1 | US FAERS | |
| 38 | apremilast | FAERS: 1 | US FAERS | |
| 39 | efinaconazole | FAERS: 1 | US FAERS | |
| 40 | mirabegron | FAERS: 1 | US FAERS | |
| 41 | palbociclib | FAERS: 1 | US FAERS | |
| 42 | suvorexant | FAERS: 1 | US FAERS | |
| 43 | Ampicillin | OFFSIDES | ||
| 44 | Atomoxetine Hydrochloride | OFFSIDES | ||
| 45 | Ertapenem | OFFSIDES | ||
| 46 | Etoposide | OFFSIDES | ||
| 47 | Gentamicins | OFFSIDES | ||
| 48 | Moxifloxacin | OFFSIDES | ||
| 49 | Oxaprozin | OFFSIDES | ||
| 50 | Tretinoin | OFFSIDES | ||
| 51 | cefpodoxime proxetil | OFFSIDES | ||
| 52 | cefpodoxime | OFFSIDES | ||
| 53 | telithromycin | Canada Vigilance: 1 | Canada Vigilance |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.